107 related articles for article (PubMed ID: 10779646)
1. Mutational analysis of the p27(kip1) gene in hepatocellular carcinoma.
Chen TC; Ng KF; Lien JM; Jeng LB; Chen MF; Hsieh LL
Cancer Lett; 2000 May; 153(1-2):169-73. PubMed ID: 10779646
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Kawamata N; Morosetti R; Miller CW; Park D; Spirin KS; Nakamaki T; Takeuchi S; Hatta Y; Simpson J; Wilcyznski S
Cancer Res; 1995 Jun; 55(11):2266-9. PubMed ID: 7757974
[TBL] [Abstract][Full Text] [Related]
3. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
4. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
[TBL] [Abstract][Full Text] [Related]
5. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
6. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
Qin LF; Ng IO
Hum Pathol; 2001 Aug; 32(8):778-84. PubMed ID: 11521219
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma.
Franke KH; Miklosi M; Goebell P; Clasen S; Steinhoff C; Anastasiadis AG; Gerharz C; Schulz WA
Urology; 2000 Oct; 56(4):689-95. PubMed ID: 11018640
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
9. Reduced p27Kip1 expression in hepatocellular carcinomas.
Hui AM; Sun L; Kanai Y; Sakamoto M; Hirohashi S
Cancer Lett; 1998 Oct; 132(1-2):67-73. PubMed ID: 10397455
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
[TBL] [Abstract][Full Text] [Related]
11. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes?
Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL
Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12.
Takeuchi S; Mori N; Koike M; Slater J; Park S; Miller CW; Miyoshi I; Koeffler HP
Cancer Res; 1996 Feb; 56(4):738-40. PubMed ID: 8631006
[TBL] [Abstract][Full Text] [Related]
13. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma.
Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T
Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337
[TBL] [Abstract][Full Text] [Related]
14. Methylation and mutational analysis of p27(kip1) in prostate carcinoma.
Kibel AS; Christopher M; Faith DA; Bova GS; Goodfellow PJ; Isaacs WB
Prostate; 2001 Sep; 48(4):248-53. PubMed ID: 11536304
[TBL] [Abstract][Full Text] [Related]
15. Expression of p27 and p53 in cervical squamous cell carcinoma patients treated with radiotherapy alone: radiotherapeutic effect and prognosis.
Oka K; Suzuki Y; Nakano T
Cancer; 2000 Jun; 88(12):2766-73. PubMed ID: 10870059
[TBL] [Abstract][Full Text] [Related]
16. Absence of APC gene mutation in the mutation cluster region in hepatocellular carcinoma.
Chen TC; Hsieh LL; Ng KF; Jeng LB; Chen MF
Cancer Lett; 1998 Dec; 134(1):23-8. PubMed ID: 10381126
[TBL] [Abstract][Full Text] [Related]
17. p27(Kip1)is overexpressed in very early stages of hepatocarcinogenesis.
Yachida S; Sakamoto M; Imaida K; Yokohira M; Saoo K; Okano K; Wakabayashi H; Maeta H; Suzuki Y
Cancer Sci; 2008 Nov; 99(11):2152-9. PubMed ID: 18808421
[TBL] [Abstract][Full Text] [Related]
18. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
19. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival.
Del Pizzo JJ; Borkowski A; Jacobs SC; Kyprianou N
Am J Pathol; 1999 Oct; 155(4):1129-36. PubMed ID: 10514396
[TBL] [Abstract][Full Text] [Related]
20. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
